Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03269748

Ligand	Ligand name	Chain	PDB	Tanimoto
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.78
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.75
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDS	0.79
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDN	0.79
TES	TESTOSTERONE	A	1JTV	0.7
TES	TESTOSTERONE	A	2Q7L	0.7
TES	TESTOSTERONE	A	2Q7I	0.7
TES	TESTOSTERONE	A,B	1J96	0.7
TES	TESTOSTERONE	A	2Q7K	0.7
TES	TESTOSTERONE	A,B	1Q13	0.7
TES	TESTOSTERONE	H	1I9J	0.7
TES	TESTOSTERONE	A,B	1AFS	0.7
TES	TESTOSTERONE	H	1VPO	0.7
TES	TESTOSTERONE	A	2Q7J	0.7
TES	TESTOSTERONE	A,B	3BUR	0.7
TES	TESTOSTERONE	A	2AM9	0.7
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.82
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.7
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.7
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.76
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.72
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.72
9OD	(2Z)-9-oxodec-2-enoic acid	A	3BFA	0.75
9OD	(2Z)-9-oxodec-2-enoic acid	A,B	3CZ0	0.75
9OD	(2Z)-9-oxodec-2-enoic acid	A,B	3CYZ	0.75
9OD	(2Z)-9-oxodec-2-enoic acid	A	3BFB	0.75
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.7
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.7
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.7
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.7
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.7
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.74
OXR	4-OXORETINOL	A,B	1X8L	0.71
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.72
VTQ	RRR-ALPHA-TOCOPHERYLQUINONE	A,C,E	1OLM	0.77
MEI	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	A,B	1UHL	0.75
PTG	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	A,B	2ZK1	0.72
PTG	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	A	2ZK2	0.72
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.72
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.72
ASY	(12E)-10-oxooctadec-12-enoic acid	A,B	3CEE	0.71
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.84